BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 2122616)

  • 21. GM2-ganglioside metabolism in cultured human skin fibroblasts: unambiguous diagnosis of GM2-gangliosidosis.
    Raghavan S; Krusell A; Lyerla TA; Bremer EG; Kolodny EH
    Biochim Biophys Acta; 1985 Apr; 834(2):238-48. PubMed ID: 3995063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The pathology of Sandhoff's disease.
    Hadfield MG; Mamunes P; David RB
    J Pathol; 1977 Nov; 123(3):137-44. PubMed ID: 592019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ultrastructural study of biopsy specimens of rectal mucosa. Its use in neuronal storage diseases.
    Yamano T; Shimada M; Okada S; Yutaka T; Kato T; Yabuuchi H
    Arch Pathol Lab Med; 1982 Dec; 106(13):673-7. PubMed ID: 6897182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurophysiological investigations in GM1 and GM2 gangliosidoses.
    Pampiglione G; Harden A
    Neuropediatrics; 1984 Sep; 15 Suppl():74-84. PubMed ID: 6100798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intracellular degradation of sulforhodamine-GM1: use for a fluorescence-based characterization of GM2-gangliosidosis variants in fibroblasts and white blood cells.
    Agmon V; Khosravi R; Marchesini S; Dinur T; Dagan A; Gatt S; Navon R
    Clin Chim Acta; 1996 Mar; 247(1-2):105-20. PubMed ID: 8920231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Manifestation of infantile GM1 gangliosidosis in the fetal eye. An electron microscopic study.
    Schmitt-Gräff A
    Graefes Arch Clin Exp Ophthalmol; 1988; 226(1):84-8. PubMed ID: 3125087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prenatal diagnosis of GM2 gangliosidosis with high residual hexosaminidase A activity (variant B1; pseudo AB variant).
    Conzelmann E; Nehrkorn H; Kytzia HJ; Sandhoff K; Macek M; Lehovský M; Elleder M; Jirásek A; Kobilková J
    Pediatr Res; 1985 Nov; 19(11):1220-4. PubMed ID: 2933632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mice lacking both subunits of lysosomal beta-hexosaminidase display gangliosidosis and mucopolysaccharidosis.
    Sango K; McDonald MP; Crawley JN; Mack ML; Tifft CJ; Skop E; Starr CM; Hoffmann A; Sandhoff K; Suzuki K; Proia RL
    Nat Genet; 1996 Nov; 14(3):348-52. PubMed ID: 8896570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. B1 variant of GM2 gangliosidosis in a 12-year-old patient.
    Goebel HH; Stolte G; Kustermann-Kuhn B; Harzer K
    Pediatr Res; 1989 Jan; 25(1):89-93. PubMed ID: 2521932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accumulation of ganglioside Gm2 in cerebrospinal fluid of a patient with the variant AB of infantile Gm2 gangliosidosis.
    Pullarkat RK; Reha H; Beratis NG
    Pediatrics; 1981 Jul; 68(1):106-8. PubMed ID: 7243492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of microtechniques for the detection of lysosomal enzyme disorders: Tay-Sachs disease, Gm1-gangliosidosis and Fabry disease.
    Bladon MT; Milunsky A
    Clin Genet; 1978 Dec; 14(6):359-66. PubMed ID: 215359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prenatal diagnosis of hereditary lysosomal diseases].
    Mirenburg TV; Aronovich EL; Lebedeva TV; Akhunov VS; Krasnopol'skaia KD
    Vopr Med Khim; 1988; 34(4):41-6. PubMed ID: 3143186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The gangliosidoses: comparative features and research applications.
    Baker HJ; Reynolds GD; Walkley SU; Cox NR; Baker GH
    Vet Pathol; 1979 Nov; 16(6):635-49. PubMed ID: 116415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of Sandhoff disease in a Thai family: clinical and biochemical characterization.
    Sakpichaisakul K; Taeranawich P; Nitiapinyasakul A; Sirisopikun T
    J Med Assoc Thai; 2010 Sep; 93(9):1088-92. PubMed ID: 20873083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of GM2-gangliosidosis (Tay-Sachs and Sandhoff disease) gene carriers by serum hexosaminidase assay.
    Molzer B; Bernheimer H
    Clin Chim Acta; 1976 Nov; 73(1):163-9. PubMed ID: 826357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GM2 gangliosidoses: a review of cases confirmed by beta-N-acetylhexosaminidase assay.
    Christopher R; Rangaswamy GR; Shetty KT
    Indian J Pediatr; 1995; 62(4):479-83. PubMed ID: 10829909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gangliosidoses.
    Patterson MC
    Handb Clin Neurol; 2013; 113():1707-8. PubMed ID: 23622392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Presence of beta-hexosaminidase A alpha-chain mRNA in two different variants of GM2-gangliosidosis.
    Budde-Steffen C; Steffen M; Siegel DA; Suzuki K
    Neuropediatrics; 1988 May; 19(2):59-61. PubMed ID: 2967444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epstein-Barr virus transformed lymphoid cell lines as a new model system in culture for the study of GM2-gangliosidoses: Tay-Sachs and Sandhoff diseases.
    Maret A; Salvayre R; Negre A; Bes JC; Douste-Blazy L
    Biol Cell; 1985; 53(3):293-6. PubMed ID: 2990625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reversibility of neuropathology in Tay-Sachs-related diseases.
    Cachón-González MB; Wang SZ; Ziegler R; Cheng SH; Cox TM
    Hum Mol Genet; 2014 Feb; 23(3):730-48. PubMed ID: 24057669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.